P2Y12 or P2Y1 inhibitors reduce platelet deposition in a microfluidic model of thrombosis while apyrase lacks efficacy under flow conditions
Author:
Publisher
Oxford University Press (OUP)
Subject
Biochemistry,Biophysics
Link
http://pubs.rsc.org/en/content/articlepdf/2010/IB/B919728A
Reference45 articles.
1. Novel Therapeutic Targets at the Platelet Vascular Interface
2. Scientific and therapeutic advances in antiplatelet therapy
3. Platelet activation mechanisms and markers in arterial thrombosis
4. The platelet P2 receptors as molecular targets for old and new antiplatelet drugs
5. The P2 Receptors in Platelet Function
Cited by 90 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Human soluble CD39 displays substrate inhibition in a substrate-specific manner;Scientific Reports;2023-06-02
2. Investigating thrombin-loaded fibrin in whole blood clot microfluidic assay via fluorogenic peptide;Biophysical Journal;2023-02
3. Thrombus remodelling by reversible and irreversible P2Y 12 inhibitors;Platelets;2023-01-11
4. “Going with the flow” in modeling fibrinolysis;Frontiers in Cardiovascular Medicine;2022-12-02
5. ADP and Thromboxane Inhibitors Both Reduce Global Contraction of Clot Length, While Thromboxane Inhibition Attenuates Internal Aggregate Contraction;TH Open;2022-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3